According to the latest report by IMARC Group, titled “Europe Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, offers a comprehensive analysis of the industry, which comprises insights on the Europe generic injectables market share. The report also includes competitor and regional analysis, and contemporary advancements in the market.
Generic injectables are drugs that have the equivalent dosage, quality, strength, performance, and intended usage as their branded counterparts. They assist in treating various life-threatening and chronic diseases, including cancer, diabetes, rheumatoid arthritis, cardiovascular ailments, respiratory infections, etc. Generic injectables aid in maximizing patient compliance and reducing the frequency of dosage, thereby maintaining the effectiveness of the treatment.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Report Sample: https://www.imarcgroup.com/europe-generic-injectables-market/requestsample
Industry Trends and Drivers:
The rising prevalence of chronic diseases, including hypertension and cardiovascular problems, represents one of the key factors driving the Europe generic injectables market. Furthermore, there is a growing demand for intravenous (IV) and intramuscular (IM) routes of drug administration for the drug delivery process and treatment of patients that are incapable of taking medicines orally. In addition to this, generic injectables are better than branded drugs in terms of cost efficiency, which is catalyzing the growth of the market. Additionally, the increasing medicine shortage and expiry of patents of branded products are expected to fuel the market growth in Europe over the forecast period.
Europe Generic Injectables Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape with Key Players:
The competitive landscape of the Europe generic injectables market has been studied in the report with the detailed profiles of the key players operating in the market.
Key Market Segmentation:
The report has segmented the Europe generic injectables market on the basis of therapeutic area, container, distribution channel and country.
Market by Therapeutic Area:
- Oncology
- Anaesthesia
- Anti-infectives
- Parenteral Nutrition
- Cardiovascular
Market by Container:
- Vials
- Ampoules
- Premix
- Prefilled Syringes
Market by Distribution Channel:
- Hospitals
- Retail Pharmacy
Market by Country:
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/europe-generic-injectables-market
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
No comments:
Post a Comment